U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote 

U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote 


U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., speaks with Agriculture Secretary Brooke Rollins and Senator Roger Marshall (R-KS) ahead of a roundtable event as part of the “Make America Healthy Again” (MAHA) agenda, on Capitol Hill in Washington, D.C., U.S., July 15, 2025.

Ken Cedeno | Reuters

The Department of Health and Human Services on Wednesday said it will officially remove the mercury-based preservative thimerosal from all flu shots distributed in the U.S. – even though there is no evidence of harm from the ingredient. 

While few jabs still contain thimerosal, the move eliminates a vaccine option for Americans and is a win for the anti-vaccine movement, which has long targeted the ingredient.

HHS Secretary Robert F. Kennedy Jr. formally adopted a June recommendation from a key government vaccine panel, called the Advisory Committee on Immunization Practices, or ACIP, against influenza shots containing thimerosal. Earlier that month, Kennedy gutted that panel and restacked it with new members, including some widely known anti-vaccine activists. 

The decision affects roughly 4% to 5% of the U.S. flu vaccine supply. That includes some multi-dose forms of Sanofi‘s Fluzone and two shots from biotech company CSL Seqirus. The rest of the nation’s flu shots were thimerosal-free during the last season of the virus, according to CDC data.

Vaccine manufacturers have confirmed that they have the capacity to replace multi-dose vials containing mercury, HHS said. That will ensure that the flu vaccine for adults and a government program that provides shots to uninsured and underinsured children won’t be interrupted, the agency added. 

Still, health experts have said that eliminating thimerosal-containing flu shots as an option for Americans could lead to fewer people receiving jabs.

The move also reinforces longstanding, unfounded fears that the substance can lead to developmental disabilities, such as autism. Kennedy’s vaccine skepticism comes full circle with ACIP’s vote: A decade before stepping into his current role, he published a book that called for the removal of thimerosal from shots and linked it to developmental disorders.

“After more than two decades of delay, this action fulfills a long-overdue promise to protect our most vulnerable populations from unnecessary mercury exposure,” Kennedy said in a release, urging global health authorities to follow suit. 

More than 40 studies over several decades have found no link between thimerosal and developmental delays. Thimerosal has been widely used for decades as a preservative to prevent the growth of harmful bacteria in several medicines and vaccines with multiple doses.

HHS said other recommendations from the panel’s meeting in June are still under review.



Source

UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More
Trump signs executive order reclassifying cannabis, opening door to broader weed access
Health

Trump signs executive order reclassifying cannabis, opening door to broader weed access

U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C., U.S., Dec. 18, 2025. Evelyn Hockstein | Reuters President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana, loosening long-standing restrictions on the drug and marking the most consequential shift in […]

Read More
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 
Health

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s injection Zepbound and Novo Nordisk’s rival shot Wegovy in a late-stage trial.  The company also said it has filed for Food and Drug Administration approval of the daily […]

Read More